Belatacept Injection 250 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mg/vial
Reference Brands: Nulojix(US)
Category: Transplant
Belatacept is a fusion protein that blocks CD80/CD86 on immune cells, preventing T-cell activation. It effectively reduces kidney transplant rejection, supports long-term graft survival, and decreases the need for intensive immunosuppressants. Benefits include targeted immunosuppression, fewer side effects, and improved quality of life for transplant recipients.
Product Description: Belatacept, marketed as Nulojix, is approved in the US by the FDA and in the EU via EMA for rejection prevention in adult kidney transplant recipients. Regulatory approval requires comprehensive dossiers, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality information, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring proper regional adherence supports timely approval, safe use, and global availability, helping transplant patients achieve optimal long-term outcomes and graft survival worldwide.
Belatacept Injection — third party manufacturing & bulk supply
Belatacept Injection 250 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Belatacept Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Belatacept Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Belatacept Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Cotrimoxazole 800Mg Tablets
Strength:
80 mg trimethoprim / 400 mg sulfamethoxazole
Form: Tablets
Reference Brands: Bactrim, Septra(US & EU)
View Details
Acyclovir Tablet
Strength:
200 mg, 400 mg, 800 mg
Form: Tablets
Reference Brands: Zovirax(US & EU)
View Details
Basiliximab Injectable Solution
Strength:
20 mg/vial
Form: Injectable Solution
Reference Brands: Simulect(US)
View Details
Quick Response Guaranteed | Verified Suppliers
